Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis

References

• Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, . Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101–10.
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 2005;236:789–800.
   PubMed Web of Science ®Google Scholar
• Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994;4:477–80.
   Google Scholar
• Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Newstead GM. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med 2008;59:747–54.
   Google Scholar
• Heywang-Kobrunner SH, Bick U, Bradley WG Jr, Bone B, Casselman J, Coulthard A, . International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 2001;11:531–46.
   Google Scholar
• Chen W, Giger ML, Bick U, Newstead GM. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med Phys 2006;33:2878–87.
   PubMed Web of Science ®Google Scholar
• Lehman CD, Peacock S, DeMartini WB, Chen X. A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity. Am J Roentgenol 2006;187:51–6.
   PubMed Web of Science ®Google Scholar
• Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989;170:681–6.
   PubMed Web of Science ®Google Scholar
• Gribbestad IS, Nilsen G, Fjosne H, Fougner R, Haugen OA, Petersen SB, . Contrast-enhanced magnetic resonance imaging of the breast. Acta Oncol 1992;31:833–42.
   PubMed Web of Science ®Google Scholar
• Manton DJ, Chaturvedi A, Hubbard A, Lind MJ, Lowry M, Maraveyas A, . Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006;94:427–35.
   PubMed Web of Science ®Google Scholar
• Martincich L, Montemurro F, De RG, Marra V, Ponzone R, Cirillo S, . Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004;83:67–76.
   PubMed Web of Science ®Google Scholar
• Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kuhn T. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002;12:1711–19.
   PubMed Web of Science ®Google Scholar
• Gilles R, Guinebretiere JM, Toussaint C, Spielman M, Rietjens M, Petit JY, . Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633–8.
   PubMed Web of Science ®Google Scholar
• Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 2001;3: 22–7.
   PubMed Web of Science ®Google Scholar
• Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 2005;104:708–18.
   PubMed Web of Science ®Google Scholar
• Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, . Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10: 260–6.
   PubMed Web of Science ®Google Scholar
• Chang YW, Kwon KH, Choi DL, Lee DW, Lee MH, Lee HK, . Magnetic resonance imaging of breast cancer and correlation with prognostic factors. Acta Radiol 2009;50:990–8.
   PubMed Web of Science ®Google Scholar
• Fernandez-Guinea O, Andicoechea A, Gonzalez LO, Gonzalez-Reyes S, Merino AM, Hernandez LC, . Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. BMC Cancer 2010;10:8.
   Google Scholar
• Pickles MD, Manton DJ, Lowry M, Turnbull LW. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. Eur J Radiol 2009;71:498–505.
   PubMed Web of Science ®Google Scholar
• Boné B, Szabó BK, Perbeck LG, Veress B, Aspelin P. Can contrast-enhanced MR imaging predict survival in breast cancer? Acta Radiol 2003;44:373–8.
   PubMed Web of Science ®Google Scholar
• Mills SJ, Patankar TA, Haroon HA, Baleriaux D, Swindell R, Jackson A. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? Am J Neuroradiol 2006;27:853–8.
   PubMedGoogle Scholar
• Ohno Y, Nogami M, Higashino T, Takenaka D, Matsumoto S, Hatabu H, . Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy. J Magn Reson Imaging 2005;21:775–83.
   PubMedGoogle Scholar
• Ljumanovic R, Pouwels PJ, Langendijk JA, Knol DL, van der Valk P, Leemans CR, . Has the degree of contrast enhancement with MR imaging in laryngeal carcinoma added value to anatomic parameters regarding prediction of response to radiation therapy? Am J Neuroradiol 2007;28:1540–6.
   Google Scholar
• Elston CW, Ellis IO, Pinder SE. Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 1999;31: 209–23.
   PubMed Web of Science ®Google Scholar
• Bundred NJ. Prognostic and predictive factors in breast cancer. Cancer Treat Rev 2001;27:137–42.
   PubMed Web of Science ®Google Scholar
• Giordano SH. Update on locally advanced breast cancer. Oncologist 2003;8:521–30.
   Google Scholar
• Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181–7.
   PubMed Web of Science ®Google Scholar
• Johansen R, Jensen LR, Rydland J, Goa PE, Kvistad KA, Bathen TF, . Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging 2009;29:1300–7.
   PubMed Web of Science ®Google Scholar
• Li KL, Partridge SC, Joe BN, Gibbs JE, Lu Y, Esserman LJ, . Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology 2008;248:79–87.
   Google Scholar
• Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244:356–78.
   PubMed Web of Science ®Google Scholar
• Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, . Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 2002;20:3628–36.
   PubMed Web of Science ®Google Scholar
• Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, . Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639–49.
   PubMed Web of Science ®Google Scholar
• Jeruss JS. Prognostic outcomes and decision-making for local-regional therapy after neoadjuvant chemotherapy: pretreatment clinical staging or posttreatment pathologic staging. Current Breast Cancer Reports 2009;1:90–7.
   Google Scholar